Dong-Jiunn Jeffery Truong

Dong-Jiunn Jeffery Truong

Auto-generated profile, based on publicly available information

Dong-Jiunn Jeffery Truong

Institute for Synthetic Biomedicine, Helmholtz Munich, Neuherberg, Germany; Department of Bioscience, TUM School of Natural Sciences, Technical University of Munich, Munich, Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2022 in EMBO Molecular Medicine
Verified
Journal Article
Open access
JGJessica Giehrl‐Schwab
Jessica Giehrl‐Schwab
FGFlorian Giesert
Florian Giesert
BRBenedict Rauser
Benedict Rauser
CLChu Lan Lao
Chu Lan Lao
SHSina Hembach
Sina Hembach
WWWolfgang Wurst
Wolfgang Wurst
Direct reprogramming based on genetic factors resembles a promising strategy to replace lost cells in degenerative diseases such as Parkinson's disease. For this, we developed a knock‐in mouse line carrying a dual dCas9 transactivator system (dCAM) allowing the conditional in vivo activation of endogenous genes. To enable a translational application, we additionally established an AAV‐based strategy carrying intein‐split‐dCas9 in combination with activators (AAV‐dCAS). Both approaches were successful in reprogramming striatal astrocytes into induced GABAergic neurons confirmed by single‐cell transcriptome analysis of reprogrammed neurons in vivo . These GABAergic neurons functionally integrate into striatal circuits, alleviating voluntary motor behavior aspects in a 6‐OHDA Parkinson's disease model. Our results suggest a novel intervention strategy beyond the restoration of dopamine levels. Thus, the AAV‐dCAS approach might enable an alternative route for clinical therapies of Parkinson's disease.

9 April 2025 in Cell
Verified
Journal Article
Open access
JGJulian Geilenkeuser
Julian Geilenkeuser
NANiklas Armbrust
Niklas Armbrust
ESEmily Steinmaßl
Emily Steinmaßl
SDSamuel W. Du
Samuel W. Du
SSSebastian Schmidt
Sebastian Schmidt
DTDong-Jiunn Jeffery Truong
Dong-Jiunn Jeffery Truong
Advanced gene editing methods have accelerated biomedical discovery and hold great therapeutic promise, but safe and efficient delivery of gene editors remains challenging. In this study, we present a virus-like particle (VLP) system featuring nucleocytosolic shuttling vehicles that retrieve pre-assembled Cas-effectors via aptamer-tagged guide RNAs. This approach ensures preferential loading of fully assembled editor ribonucleoproteins (RNPs) and enhances the efficacy of prime editing, base editing, trans-activators, and nuclease activity coupled to homology-directed repair in multiple immortalized, primary, stem cell, and stem-cell-derived cell types. We also achieve additional protection of inherently unstable prime editing guide RNAs (pegRNAs) by shielding the 3'-exposed end with Csy4/Cas6f, further enhancing editing performance. Furthermore, we identify a minimal set of packaging and budding modules that can serve as a platform for bottom-up engineering of enveloped delivery vehicles. Notably, our system demonstrates superior per-VLP editing efficiency in primary T lymphocytes and two mouse models of inherited retinal disease, highlighting its therapeutic potential.

1 February 2024 in Nature Methods
Verified
Journal Article
Open access
PDF file
DTDong-Jiunn Jeffery Truong
Dong-Jiunn Jeffery Truong
JGJulian Geilenkeuser
Julian Geilenkeuser
SWStephanie Victoria Wendel
Stephanie Victoria Wendel
JWJulius Clemens Heinrich Wilming
Julius Clemens Heinrich Wilming
NANiklas Armbrust
Niklas Armbrust
GWGil Gregor Westmeyer
Gil Gregor Westmeyer
Prime editing (PE) is a powerful gene-editing technique based on targeted gRNA-templated reverse transcription and integration of the de novo synthesized single-stranded DNA. To circumvent one of the main bottlenecks of the method, the competition of the reverse-transcribed 3′ flap with the original 5′ flap DNA, we generated an enhanced fluorescence-activated cell sorting reporter cell line to develop an exonuclease-enhanced PE strategy (‘Exo-PE’) composed of an improved PE complex and an aptamer-recruited DNA-exonuclease to remove the 5′ original DNA flap. Exo-PE achieved better overall editing efficacy than the reference PE2 strategy for insertions ≥30 base pairs in several endogenous loci and cell lines while maintaining the high editing precision of PE2. By enabling the precise incorporation of larger insertions, Exo-PE complements the growing palette of different PE tools and spurs additional refinements of the PE machinery.

3 June 2021 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
DTDong-Jiunn Jeffery Truong
Dong-Jiunn Jeffery Truong
TPTeeradon Phlairaharn
Teeradon Phlairaharn
BEBianca Eßwein
Bianca Eßwein
CGChristoph Gruber
Christoph Gruber
DTDeniz Tümen
Deniz Tümen
GWGil Gregor Westmeyer
Gil Gregor Westmeyer
Expression of exon-specific isoforms from alternatively spliced mRNA is a fundamental mechanism that substantially expands the proteome of a cell. However, conventional methods to assess alternative splicing are either consumptive and work-intensive or do not quantify isoform expression longitudinally at the protein level. Here, we therefore developed an exon-specific isoform expression reporter system (EXSISERS), which non-invasively reports the translation of exon-containing isoforms of endogenous genes by scarlessly excising reporter proteins from the nascent polypeptide chain through highly efficient, intein-mediated protein splicing. We applied EXSISERS to quantify the inclusion of the disease-associated exon 10 in microtubule-associated protein tau (MAPT) in patient-derived induced pluripotent stem cells and screened Cas13-based RNA-targeting effectors for isoform specificity. We also coupled cell survival to the inclusion of exon 18b of FOXP1, which is involved in maintaining pluripotency of embryonic stem cells, and confirmed that MBNL1 is a dominant factor for exon 18b exclusion. EXSISERS enables non-disruptive and multimodal monitoring of exon-specific isoform expression with high sensitivity and cellular resolution, and empowers high-throughput screening of exon-specific therapeutic interventions.

7 November 2022 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
DTDong-Jiunn Jeffery Truong
Dong-Jiunn Jeffery Truong
NANiklas Armbrust
Niklas Armbrust
JGJulian Geilenkeuser
Julian Geilenkeuser
ELEva-Maria Lederer
Eva-Maria Lederer
TSTobias Heinrich Santl
Tobias Heinrich Santl
GWGil Gregor Westmeyer
Gil Gregor Westmeyer
Despite their fundamental role in assessing (patho)physiological cell states, conventional gene reporters can follow gene expression but leave scars on the proteins or substantially alter the mature messenger RNA. Multi-time-point measurements of non-coding RNAs are currently impossible without modifying their nucleotide sequence, which can alter their native function, half-life and localization. Thus, we developed the intron-encoded scarless programmable extranuclear cistronic transcript (INSPECT) as a minimally invasive transcriptional reporter embedded within an intron of a gene of interest. Post-transcriptional excision of INSPECT results in the mature endogenous RNA without sequence alterations and an additional engineered transcript that leaves the nucleus by hijacking the nuclear export machinery for subsequent translation into a reporter or effector protein. We showcase its use in monitoring interleukin-2 (IL2) after T cell activation and tracking the transcriptional dynamics of the long non-coding RNA (lncRNA) NEAT1 during CRISPR interference-mediated perturbation. INSPECT is a method for monitoring gene transcription without altering the mature lncRNA or messenger RNA of the target of interest.

29 May 2025 in Nature Methods
Verified
Journal Article
Open access
PDF file
RMRuyu Ma
Ruyu Ma
LSLuciano M. Santino
Luciano M. Santino
TCTomáš Chobola
Tomáš Chobola
NANiklas Armbrust
Niklas Armbrust
JGJulian Geilenkeuser
Julian Geilenkeuser
JCJian Cui
Jian Cui
Bioluminescence is an attractive alternative to fluorescence for live-cell imaging; however, its low intensity has prevented widespread adoption. Specialized microscopes compensate by sacrificing spatial resolution, field of view and dynamic range—constraints imposed by the highest-sensitivity camera to date: the electron-multiplying charge-coupled device. Recently, quanta image sensor (QIS) technology has emerged for low-light imaging. Here, we show that a commercial QIS camera has exceptional sensitivity; however, its sensor dimensions necessitate a microscope designed to maximize its properties. We introduce a Keplerian-telescope-inspired microscope setup that, with the QIS, results in modestly improved signal-to-noise ratios at substantially higher spatial resolution, field of view and dynamic range, relative to the state of the art. The telescopic design also confers modularity, enabling multimodal imaging with epifluorescence. The ‘QIScope’ makes bioluminescence a viable tool for technically challenging live-cell experiments such as monitoring intracellular and extracellular vesicles simultaneously and the dynamics of low-abundance proteins.